Singapore
Biobot Surgical
SGD 20.0M
startup
Summary
Biobot Surgical raised SGD 20 million in its latest financing round to accelerate adoption of its prostate care platform and support entry into the US market. The round was led by ClavystBio in partnership with ZIG Ventures. Biobot Surgical is a medical technology company developing robotic-assisted systems for prostate cancer diagnosis and treatment.